Forecast & Rating6 analysts currently cover Enhabit Home Health & Hospice, with about 0.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $13.80, about 0.0% upside from the current price of $13.80. Historically, about 74.7% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Enhabit Home Health & Hospice's outlook. Data as of May 8, 2026; for reference only and not investment advice.
Apr 10, 2026Price forecast
$13.800.00%
Forecast & RatingHold
6analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateMay 10, 2026
Forecast met64.5%
Stock price$13.80
Avg. target$9.8
High target$12
Low target$9
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.